EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy

Bastien Bourrion, Henri Panjo, Brice Fresneau, Laura Lenez, Florent de Vathaire, Mathilde François, Nathalie Pelletier-Fleury

Journal of Cancer Survivorship · 2026-10 · 20 (S2) · 2009-2019

DOI: 10.1007/s11764-026-02032-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Survivorship, online erschienen am 08.05.2026. Verfasst von Bastien Bourrion und 6 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, Université Paris-Saclay, UVSQ, CESP, Hôpital Paul Brousse, bâtiment 15/16 Inserm, 16 Avenue Paul Vaillant Couturier, 94807, Villejuif Cedex, …. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Radiotherapy, Infertility. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université de Versailles Saint-Quentin-en-Yvelines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This retrospective cohort study estimated the healthcare expenditure of infertility treatment in women who survived childhood cancer and analyzed associated factors using data from the French Childhood Cancer Survivor Study (FCCSS) cohort. Patients and methods From 2578 women in the FCCSS cohort, 118 exposed who received infertility treatment, aged 18–42, were identified based on first recorded drug therapy and/or in vitro fertilization/intracytoplasmic sperm injection and/or medically assisted procreation between 2011 and 2018. Six hundred eight unexposed who had not undergone infertility treatment were selected using propensity score matching. Expenditure related to infertility treatment was estimated as the difference between cases’ expenditures and average expenditures of their controls yearly, over a maximum follow-up period of 4 years unexposed.

Results

Average annual expenditure related to infertility treatment per patient over 4 years was 3043 euros (95% CI: 2240; 3845) (in euros 2025). Expenditure peaked during the first 2 years and among women aged 25–35. Patients treated with radiotherapy alone had higher average annual expenditure of 4531 euros (95% CI: 1781; 7281). In multivariate analysis, radiotherapy alone and chemotherapy alone were associated with increased annual expenditure of 4382 euros (95% CI: 1102.0; 7661.3) and 2018 euros (95% CI: 97.3; 3937.8), respectively, compared to patients without childhood radiotherapy or chemotherapy. Combined radiotherapy and chemotherapy increased infertility-related expenditure (€2132.5 (95% CI: −36.6; 4301.6), p : 0.054) compared with patients who received neither of these two treatments. The magnitude, trends of expenditure, and age at initiation of infertility treatment were consistent with the general population.

Conclusion

Implications for Cancer Survivors The study shows that childhood cancer treatment modalities significantly influence expenditures related to infertility treatment in women, which are implicitly attributable to the adverse effects of these treatments,with radiotherapy being a key driver. These findings support developing public health strategies promoting more targeted paediatric cancer treatments to mitigate long-term costs, particularly those associated with infertility treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsNeoplasmsRadiotherapyInfertilityHealth Care CostsInfertility, FemaleHumansFemaleAdultRetrospective StudiesAdolescentYoung AdultChildFrance

Stichwörter der Autor:innen

Cancer treatmentsChildhood cancer survivorsCost analysisInfertility

Autor:innen und Institutionen

  • INSERM, Université Paris-Saclay, UVSQ, CESP, Hôpital Paul Brousse, bâtiment 15/16 Inserm, 16 Avenue Paul Vaillant Couturier, 94807, Villejuif Cedex, France. bastien.bourrion@uvsq.fr.
  • Département de Médecine Générale, Faculté des Sciences de la Santé Simone Veil, UVSQ, 2 Avenue de la Source de la Bièvre, 78180, Montigny le Bretonneux, France. bastien.bourrion@uvsq.fr.
  • INSERM, Université Paris-Saclay, UVSQ, CESP, Hôpital Paul Brousse, bâtiment 15/16 Inserm, 16 Avenue Paul Vaillant Couturier, 94807, Villejuif Cedex, France.
  • Radiation Epidemiology Group, University of Paris Saclay, Gustave Roussy, Inserm, Unit 1018-CESP, Villejuif, France.
  • Département de Cancérologie de l'Enfant et de l'Adolescent, Gustave Roussy, F-94805, Villejuif, France.
  • Département de Médecine Générale, Faculté des Sciences de la Santé Simone Veil, UVSQ, 2 Avenue de la Source de la Bièvre, 78180, Montigny le Bretonneux, France.

Förderung

  • Université de Versailles Saint-Quentin-en-Yvelines

Zitieren

APA

Bourrion, B., Panjo, H., Fresneau, B., Lenez, L., de Vathaire, F., François, M., & Pelletier-Fleury, N. (2026). Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy. Journal of Cancer Survivorship, 20(S2), 2009-2019. https://doi.org/10.1007/s11764-026-02032-2

Vancouver

Bourrion B, Panjo H, Fresneau B, Lenez L, de Vathaire F, François M, et al. Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy. Journal of Cancer Survivorship. 2026;20(S2):2009-2019. doi:10.1007/s11764-026-02032-2

BibTeX
@article{Bourrion2026,
  author = {Bourrion, Bastien and Panjo, Henri and Fresneau, Brice and Lenez, Laura and de Vathaire, Florent and François, Mathilde and Pelletier-Fleury, Nathalie},
  title = {Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy},
  journal = {Journal of Cancer Survivorship},
  year = {2026},
  volume = {20},
  number = {S2},
  pages = {2009--2019},
  doi = {10.1007/s11764-026-02032-2}
}
Kostenlos starten →